MedPath

Norepinephrine Weaning in Septic Patients

Phase 4
Completed
Conditions
Septic Shock
Interventions
Device: norepinephrine infused under computerized fuzzy logic control
Device: norepinephrine infused at the clinician's discretion
Registration Number
NCT00763906
Lead Sponsor
Association pour le Développement de la Recherche et de l'Enseignement en Médecine d'Urgence
Brief Summary

The weaning rate of vasopressors drugs is usually chosen empirically by the clinician in critically patients. The investigators applied fuzzy logic principles to modify intravenous norepinephrine infusion rates during norepinephrine infusion in septic patients in order to reduce the duration of shock. The investigators goal was to reduce the duration of poorly controlled hemodynamic status.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Septic shock
Exclusion Criteria
  • Less than 18 years
  • Pregnancy
  • Weight above 135 kg
  • Requirement for continuous epinephrine infusion
  • Severe head injury, stroke, a comatose state following cardiac arrest

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2norepinephrine infused under computerized fuzzy logic controlPatients were assigned to norepinephrine infused under computerized fuzzy logic control.
1norepinephrine infused at the clinician's discretionPatients were assigned to norepinephrine infused at the clinician's discretion.
Primary Outcome Measures
NameTimeMethod
Time to shock resolution defined as cessation of vasopressor support
Secondary Outcome Measures
NameTimeMethod
28 days survival, total amount of norepinephrine infused, duration of mechanical ventilation, and length of stay in the ICU

Trial Locations

Locations (1)

Réanimation

🇫🇷

Bobigny, Seine-Saint-Denis, France

© Copyright 2025. All Rights Reserved by MedPath